There are more than 100,000 varieties of
mushrooms on this planet, and
hundreds are edible. In laboratory tests (mostly in Japan and China), a
few dozen species have been confirmed to have medicinal properties. An
extract from maitake mushrooms called D fraction is marketed as a dietary
supplement.
Maitake Beta-Factor, Planetary
Formulas

Dr. Nanba's Maitake Beta-Factor by Planetary
Formulas contains Dr. Nanba's unique MaitakeGold 404 beta-glucan fraction,
the fully mature fruiting body and the mycellium. This provides a complete
spectrum of maitake activity.
Lifestyle Recommendations: To support immune defenses, get enough rest,
drink plenty of pure water, exercise regularly, avoid excessive stress and
supplement the diet with antioxidant nutrients.
Consists of MaitakeGold 404 which is a trademark of The Tradeworks Group,
Inc. U.S. Patent number 5,854,404.
Maitake Supplement Facts:
Vitamin C (as ascorbic acid)
Calcium
Maitake ( beta-glucan ) Fraction
Maitake Blend
Maitake Fruiting Body and Maitake Myceila Biomass.
Click here to learn more about Maitake Mushroom supplement or to sign up to a FREE,
highly touted newsletter
Subscribe
to a
FREE
Supplement
Research Update newsletter. Twice a month we email a brief abstract
of several studies on various supplements and natural medicine topics, including
maitake mushroom, and
their practical interpretation by Ray Sahelian, M.D.
Benefit of Maitake Mushroom:
Benefit of Maitake and cancer
Maitake mushroom is used with chemotherapy to treat
breast cancer and
other cancers in Asia. Laboratory studies show that Maitake extract can reduce
the growth of cancer in animals.
Human studies are needed before understanding the role of maitake mushroom in
clinical cases of human cancer treatment.
Maitake and immune system
Maitake extract is thought to benefit the
immune system, and some
people take this mushroom extract in order to reduce the occurrence of the
common cold and
the flu. Whether maitake is able to do this is not clear at this time.
Maitake Mushroom Research Update
Maitake D Fraction enhances antitumor effects and reduces
immunosuppression by mitomycin-C in tumor-bearing mice.
Nutrition. 2005 May;21(5):624-9.
D-Fraction, a polysaccharide extracted from maitake mushrooms (Grifola
frondosa), has been reported to exhibit an antitumor effect through activation
of immunocompetent cells, including macrophages and T cells, with modulation of
the balance between T-helper 1 and 2 cells. We examined whether maitake D
Fraction could decrease the effective dosage of the chemotherapeutic agent,
mitomycin-C (MMC), necessary to control carcinoma in mice. CONCLUSION: These
results suggest that maiteke D-Fraction can decrease the effective dosage in
tumor-bearing mice by increasing the proliferation, differentiation, and
activation of immunocompetent cells and thus provide a potential clinical
benefit for patients with cancer.
Potential growth inhibitory effect of maitake D-fraction on canine cancer
cells.
Vet Ther. 2004 Winter;5(4):263-71.
The postulated anticancer effect of maiteke D-fraction, the bioactive extract
of maitake mushroom, on three types (CF33, CF21, and CL-1) of canine cancer
cells was evaluated. The effect of maitake D-fraction on several human cancer
cells was also investigated. The effect of other beta-glucan products was
likewise examined. Maitake D-fraction was highly effective on the canine cancer
cells, either potently inhibiting cell growth or directly killing cells. Similar
effects were also demonstrated in certain human cancer cells. However, other
beta-glucan products relevant to D-fraction had no such effects on canine cancer
cells. Therefore, maitake D-fraction is a potent natural agent that could be
useful in treating canine cancers as well as other veterinary cancers.
Effects of D-Fraction, a polysaccharide from Grifola frondosa on tumor
growth involve activation of NK cells.
Biol Pharm Bull. 2002 Dec;25(12):1647-50.
Natural killer (NK) cells are directly cytotoxic for tumor cells and play a
primary role in regulating immune responses. We monitored levels of NK cell
cytotoxic activity in cancer patients receiving maitake D-Fraction extracted
from maitake mushrooms (Grifola frondosa). Elevated levels of cytotoxic activity
were maintained for one year. To elucidate the mechanisms underlying long-term
activation of NK cells during treatment with maitake D-Fraction, we examined
tumor volume and levels of IFN-gamma and TNF-alpha in MM46-bearing C3H/HeN mice
to which D-Fraction was administered for 19 d. Maitake D-Fraction markedly
suppressed tumor growth, corresponding with increases in TNF-alpha and IFN-gamma
released from spleen cells and a significant increase in TNF-alpha expressed in
NK cells. This suggests that the maitake D-Fraction activates NK cells even on
the 20th day after treatment. Furthermore, D-Fraction increased
macrophage-derived interleukin (IL)-12, which serves to activate NK cells. These
results suggest that NK cells are not only responsible for the early effects of
D-Fraction on tumor growth, but also for the long-term tumor-suppressive effects
of maitake D-Fraction through increased IL-12 released from macrophages.
Antihypertensive and metabolic effects of whole Maitake mushroom powder
and its fractions in two rat strains.
Mol Cell Biochem. 2002 Aug;237(1-2):129-36.
Talpur NA, Echard BW, Fan AY, Jaffari O, Bagchi D, Preuss HG. Department of
Physiology and Biophysics, Georgetown University Medical Center, Washington,
DC
Maitake mushroom has been reported to favorably influence
hypertension and
diabetes mellitus. The purpose of this study was to compare the effects of whole Maitake mushroom powder and two extracts designated as ether soluble (ES) and
water soluble (WS) on Zucker fatty rats (ZFR), a model of insulin resistance,
and on spontaneously hypertensive rats (SHR), a model of genetic hypertension.
In the initial study, we followed four groups of eight ZFR and SHR receiving
special diets: a baseline diet (BD), BD + whole Maitake mushroom powder (20%
w/w), BD + fraction ES (0.10% w/w), and BD + WS (0.22% w/w). We conclude that
the examined forms of Maitake mushroom have antihypertensive and antidiabetic
potential which differ among rat strains. The ES fraction may decrease SBP in
SHR via alteration in the renin-angiotensin system.
The effect of maitake mushrooms on
liver and serum lipids.
Altern Ther Health Med. 1996 Sep;2(5):62-6.
To determine the efficacy of maitake mushrooms in inhibiting the elevation of
liver and serum lipids in rats. Sprague-Dawley rats with hyperlipidemia
were used to measure and compare the values of cholesterol, phospholipids, and
triglycerides between cholesterol-fed rats and rats whose diets were fortified
with 20% maitake mushroom dried powder. The values in maitake -fed rats
were consistently less than those in the basic cholesterol-fed rats. The value
of high-density lipoprotein cholesterol, which usually is decreased by taking
high-cholesterol feed, maintained the level that it had at the beginning of the
experiment. Weights of extirpated liver and epididymal fat pads were
significantly less than those in the basic feed group. CONCLUSION: Our data
suggest that maitake mushrooms have the ability to alter lipid metabolism by
inhibiting both the accumulation of liver lipids and the elevation of serum
lipids. Further studies are needed to elucidate the mechanism of activity of
maitake mushrooms and to establish whether their action in humans is similar to
that in the animal model tested here.
Maitake Products, Inc. (MPI), a leader of research and development of Japanese Maitake mushrooms and other medicinal mushrooms, was recently named a corporate cancer research sponsor of the Memorial Sloan-Kettering Cancer Center in New York City. The awarding of this honor reflects the support that MPI is giving to the renowned cancer research and treatment center in its quest to improve methods for treating this deadly disease. In 1999, Memorial Sloan-Kettering inaugurated a department called Integrative Medicine Service, which is committed to providing complementary medicine treatment modalities to patients, in conjunction with conventional cancer treatments. This department is also responsible for carrying out clinical trials on promising complementary medicine treatments. One of the studies currently ongoing involves an extract of the Maitake mushroom specially made for the study. The goal of this study is to measure immune system activation in breast cancer patients and side effects, if any.
Maitake mushroom patent
Maitake Products, Inc., after many years of research and development with
the active glycoprotein of the Maitake mushroom, has officially been granted a
U.S Patent. Maitake Products, Inc., along with the inventors, has been awarded
“U.S. Patent No. 7,214,778 for “GLYCOPROTEIN WITH ANTIDIABETIC,
ANTIHYPERTENSIVE, ANTIOBESITY AND ANTIHYPERLIPIDEMIC EFFECTS FROM GRIFOLA
FRONDOSA, AND A METHOD FOR PREPARING SAME”. Maitake Products, Inc., in
collaboration with researchers in both the U.S. and Japan, have found the
anti-diabetic activities of this specific glycoprotein ( SX-Fraction ) extracted
from Maitake mushroom. Such researchers include Dr. Harry Preuss of Georgetown
University, Dr. Hirokazu Kawagishi of Shizuoka University (Japan), and Dr.
Sensuke Konno of N.Y. Medical College. SX-Fraction has been available in
vegetable tablet form as a finished product by Maitake Products, Inc. The
company will also offer SX-Fraction in a standardized extract form as a raw
material labeled “PSX-Fraction” to qualified manufacturers.
Maitake Questions
Q. Is it okay to take
lipoic acid and coQ10
the same day as a maitake mushroom extraxt?
A. I don't see why not as long as the dosage of lipoic
and coq10 are kept low.
Q. Does
AHCC come from maitake mushroom?
A. To my knowledge, AHCC is derived mostly from
shiitake mushroom.
Q. Can I take a maitake mushroom supplement the same
day as serrapeptase
enzyme
or mangosteen herb?
A. You can probably take it with mangosteen, but there
is not enough known about serrapeptase to know for sure.
Q. Do you know of any negative effects resulting from
the use of Maitake D-Fraction and PawPaw Cell-Reg?
A. Not enough human studies have been done with Maitake
D-Fraction to know its full side effect profile. We are not familiar with PawPaw
Cell-Reg product.
Q. Does maitake benefit anxiety?
A. I don't have personal experience regarding maitake
and anxiety treatment, and I have not seen studies in this regard.
Q. I read that maitake mushroom is good for immune
system and supressing cancerous tumors. they never say how many maitake pills to
take. I am sure the amount on the bottle is for general health maintenance. if
you already have a cancerous tumor and are in good health otherwise, how much
maitake mushroom dosage should you take? so far I am taking 9 maitake pills a
day. I am going to have surgery but would like the mushrooms to be of help so
want to treat it like a drug.
A. Since human research with maitake mushroom extract is very
limited, and since there are many different forms of cancer and many different
types of maitake mushroom supplements and extracts, and each person is different
in their response and severity of their cancer, no easy answers are available.
Q. What dose of maitake mushroom extract would you give
to a 45 ld. dog that recently had her spleen removed because of tumors on the
spleen. She is a healthy dog and very active. She also had a basal cell tumor
removed from her side earlier this year which was cancerous. We are waiting for
the biopsy results on the spleen.
A. Regarding the use of maitake mushroom in a dog or animal is
outside of our range of knowledge.
Q. I would like to know if maitake mushroom can be
taken during pregnancy. I was just told by my doctor that I am pregnant.
A. Oct 2007 - We did a search on Medline with the keywords maitake
pregnancy and maitake pregnant and could not find any studies. Most likely small
dosages would be safe, but we have no proof of this. As a general rule, unless
necessary, it is best to minimize the used of herbs and medicines during
pregnancy.
Maitake Mushroom 15%, 20% Polysaccharides --
maitake sx fraction
Maitake product for sale